You are here: Home - Home page updates news, Sidebar updates news, updates - Guidelines for First-line Treatment of RLS, Prevention and Treatment of Augmentation


Guidelines for First-line Treatment of RLS, Prevention and Treatment of Augmentation


SLEEP MEDICINE Journal:

Title:  Guidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-Foundation
ISSN: 1389-9457
DOI: 10.1016/j.sleep.2016.01.017
URL: http://dx.doi.org/10.1016/j.sleep.2016.01.017

==================================================================

WHITE PAPER SUMMARY OF RECOMMENDATIONS FOR THE PREVENTION AND TREATMENT OF RLS/WED AUGMENTATION
A COMBINED TASK FORCE OF THE IRLSSG, EURLSSG AND THE RLS‐FOUNDATION

Click on below link to download the paper.   For permission to reproduce or distribute the paper contact secretary@irlssg.org.

Click here: Summary of recommendations RLS Augmentation 13Aug2015 (PDF)
(updated on August 13, 2015 with corrected serum ferritin level)

Members of the Task Force

Diego Garcia‐Borreguero, MD, Madrid, Spain*
Richard P. Allen, PhD, Baltimore, MD, USA*
Michael H. Silber, MBChB, Rochester, MN, USA*
John W. Winkelman, MD, Boston, MA, USA*
Birgit Högl, MD, Innsbruck, Austria*
Jacquelyn Bainbridge, PharmD, Denver, CO, USA
Mark Buchfuhrer, MD, Downey, CA, USA
Georgios Hadjigeorgiou, MD, Thessaly, Greece
Yuichi Inoue, MD, Tokyo, Japan
Mauro Manconi, MD, Lugano, Switzerland
William Ondo, MD, Houston, TX, USA
Juliane Winkelmann, MD, Stanford, CA, USA
*Member of the writing committee

One thought on “Guidelines for First-line Treatment of RLS, Prevention and Treatment of Augmentation

Leave a Reply

Your email address will not be published. Required fields are marked *